SEC filing · 8-K

Sonoma Pharmaceuticals, Inc.: Material agreement

Sonoma Pharmaceuticals adopted a new Section 382 rights agreement to protect its net operating loss tax assets.

Filed October 6, 2026

Neutral news

What happened

On October 6, 2026, the board of directors approved and entered into a Section 382 Rights Agreement with Computershare Inc.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Sonoma Pharmaceuticals, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.